compromising attitude to it-just as we have towards other 'civilized' activities which can harm not only ourselves but others, e.g. drinking, gambling, driving, and over-eating.
A patient's view of asthma I read the paper by Donaldson (October 1995 jRSM, pp 590P-593P) with great interest. In it he points out, as he does in his book, how the patients' construction of their illness, in his case asthma, may be very different from that of the doctor who suggests his treatment. The patient builds from their own experience a picture of illness which may be quite different from that of friends and acquaintances and doctor. Parents are afraid to ask questions about the complaint or its treatment or how or why medicines act to be effective. Patients think that asthma is variable and mostly unpredictable. Donaldson was worried that after 60 years of asthma doctors could not explain why his asthma was becoming worse rather than better. Tragically and unexpectedly he died of asthma in August 1994, What a pity that in the note about this he is referred to as Doctor Donaldson. He never stopped putting forward the layman's point of view about the causes and treatment of asthma. 
A W Frankland

Get some research under your belt
Tom Treasure's editorial (August 1995 jRSM, PI' 425-426) raised a number of points regarding the role of research in the training of a doctor. If I understand him correctly, he believes that research is part of the proper training for a consultant (and why not all of us), so that the proper mix of intellect and technology can be practised, but that a doctoral dissertation--an MS or MD rather than a PhD is not a requirement for a consultant and certainly should not be part of the entry criteria for further training at senior registrar level. He does, however, encourage presentation at the RSM, and publication in peer reviewed journals as objective evidence of a grasp of research methods and critical evaluation of data. No one could argue against these as being worthy, although they may be criticized since the actual contribution of the individual, especially if junior, may be difficult to assess in a multi-authored article or presentation. What is difficult to understand is the objection to the MS or MD-'the slavish completion to a thesis as an end to itself'. I agree that for some trainees if this is to be undertaken it may be better done later in training but in a busy programme, time may be a problem and a year's .absence for research too difficult to contemplate while on the last lap of the training circuit. Surely the MD done in mid training, perhaps using normal study leave, demonstrates all the intellectual qualities related to most publications and also the tenacity necessary to actually get it finished into a dissertation. It is also likely to be the candidate's own work and although he may have spent '2-3 years up a blind alley doing so-called research' it's the journey not the destination that counts. Even being used as a 'pair of hands in someone else's molecular biology laboratory' (it could hardly be in his own) would show the ability to collect, assimilate and analyse data-not a bad asset for any established physician. Sure, papers and presentations are worthwhile, but so is the dissertation when we evaluate trainee performance. If the object of the editorial was purely to suggest that research generally should be left for later in training, or that a formal research degree is not a requirement for a consultant, that is understandable, though not necessarily agreeable, but what comes through is a prejudice i? favour of informal, opportunistic and applied research, rather than dedicated, formal and possibly basic research. It's a pity that trainees reading the editorial would not be told the best reasons for doing research-for fun and excitement-which is completely missing. The author replies below:
I am grateful to Dr Roath for taking an interest in my comments. I suspect that in truth we would find a large measure of agreement in our views on the place of research in the training and career development of doctors but there are some points which need clarification.
I was writing with the current British situation in mind. Here the title 'consultant' is used for all physicians and surgeons in NHS hospital t'ractice. Therefore it is 'all of us' as far as surgeons are concerned, with very few exceptions. The degree by thesis often takes 2 years of research work and in many instances drags on over 3 or 4 years. It had become a hurdle which had to be passed by trainees in the major specialities before they could progress from registrar to senior registrar and was being used as a very crude filter half way through an already protracted 10-12 years of training. I do not believe there is an equivalent hurdle in the USA.
Weare trying hard to rationalize and improve our training by introducing Caiman's recommendations and I was alarmed to find that juniors were being advised to 'get their research out of the way early' which I suspect is a turn of phrase which would be as irksome to Dr Roath as it was to me since it suggests a dull chore rather than the 'fun and excitement' that I am sure keeps us both interested in research.
Finally, Dr Roath, 'prejudice' can be revealed in various ways! The adjectives 'informal, opportunistic and applied' are grouped in contradistinction to another trio 'dedicated, formal and basic' . Surely, whether the research is basic or applied, it should it be formal, structured, purposeful, competently supervized and well directed, rather than opportunistic, contrived, underpowered and whimsical? First, Americans rarely believe that a generalist m~be best, either alone or making a referral. HMOs are having to change this fun~amental attitude, possibly a harder job than financial restructuring.
Secondly, the health care reform proposal, led by Mrs Clinton, was to create huge, multiagencybureaucracies(somewhat reminiscent of the UK where administrators have multiplied whilst hospital bedspacc has contracted). The sluggish pace (an extended period needed to educate the team) and the inelegant proposal were probably related to a team inexperienced in this area. Meanwhile, Mr Clinton's political opposition (who have undergone a renaissance during the last 2 years) were broadcasting an anti-bureaucracy message, usingthe health-care proposal as an example.
Big contrasts between American and English hospitals are aesthetic or logistical, not technical. Operating rooms in the USA do not have the typical UK list of 8-10 patients, day-in and day-out; fixed costs are thus assigned over fewer cases. Tangential, 'hotel' services overwhelm the cost of technical services (drugs, clinical staff, ctc.) of hospitals in the USA today. Pharmacoeconomic and health care utilization improvements cannot identify sufficient reduction in total health care costs. American hospitals spend a lot of money on decoration. Ex-servicemen (of whom many are now of the ageing, 'baby-boom' generation) using the Veterans' Admininstration, are often ignored in this debate, and their hospitals look much more like those operated by the NHS.
The Janet Nash Travelling Fellowship, Johnson and Haranden (January 1994 JRSM, pp 47-49) are to be congratulated. If we are to understand and make progress in health care delivery in any country of the world, then we need perspectives such as these, from other countries, to help us form our ideas.
Anthony W Fox
Cypros Pharmaceutical Corporation. Carlsbad, CA 92008, USA
Population strategy for preventive medicine
Dr Bruce Charlton's critique of Geoffrey Rose's population strategy for preventive medicine (November 1995 jRSM, pp 607-610) endorses the attitude of many academic medical investigators, who depreciate theories of multiple causation of disease based on epidemiology as ignorant, and insist that preventive measures must await full elucidation of a complete causal chain, identifying the single necessary cause.
As a houseman at the Brompton Hospital [ dined from an endowed kitchen because the founding benefactors recognized good nutrition as a preventive measure against consumption, and did not wait another 40 years for Koch's discovery of the tubercle bacillus. The discovery of this single, necessary cause had no impact on the mortality trends from tuberculosis, which continued their steady decline for another 70 years until the advent of antibiotics, responding to public health measures and improving living conditions. In Britainin the 19305more children's lives were lost, compared with other countries, because academic debate delayed the introduction of immunization with diphtheria toxoid. Should we have waited another 40 years, until the necessary cause of the diphtheria bacillus' virulence was shown to be its infection with a bacteriophage? Who blows the whistle when the cause is definitely proven? Dr Charlton's article was published in the week it was announced that the public campaign to put infants to sleep on their backs had resulted in a 75% reduction in sudden infant deaths, Does Dr Charlton want to undo this advice because the Single necessary cause is not known, and the disease is only at what he sees as the pnmltlve multiple risk factor stage of epidemiology, rather than that of true scientific understanding?
Governments are not the mindless bullies that he presumes. They respond to public pressure, and can only get away with what the public accepts~a public which is , increasingly reluctant to have its life-style, environment and diseases determined purely by the operation of a free market, and which would like a public health interest at the centre of decision making.
Hippocrates' aphorism 'first do no harm' certainly applies to public health as well as clinical medicine, but the decision to do nothing can be more dangerous than a pragmatic judgement made in the light of partial evidence. In politics, business and war, insisting on doing nothing until you understand everything is a recipe for failure. The same is true in public health even though a perfectionist approach may be attractive to philosophers, theorists and ethicists.
Hugh TunstaII-Pedoe Cardiovascular Epidemiology Unit, Ninewells Hospital and Medical School,
University of Dundee, Scotland
Ocular and renal sarcoidosis
It would be wrong if the message in the case report of Shah and colleagues (October 1995 jRSM, pp 597-598) were accepted uncritically. Granulomatous interstitial nephritis due to sarcoidosis, with or without eye involvement, is not 'excessively rare'.
Hannedouchc a al,' reviewed 57 published cases of sarcoid granulomatous interstitial nephritis including six of their own. Eighteen patients, nearly one-third, had associated sarcoid eye disease. Many cases go unreported", It is curious that the paper Shah and colleagues quote as the only one describing the association of eye and renal involvement in sarcoidosis clearly states in the summary that sarcoidosis was excluded. Rosenbaum! describes five cases (not four) of a condition unrelated to sarcoidosis, tubule-interstitial nephritis and uveitis, where the interstitial nephritis is not granulomatous.
Cyclophosphamide, as used in Shah's patient with serious consequences, is a lifesaving drug in Wegener's granulomatosis but entirely inappropriate in sarcoidosis.
B I Hofibrand
The Whittington Hospital, Highgate Hill, London N1g 5NF. England
